Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 One-year Kaplan-Meier estimates of the invasive treatment arms for the patients with diabetes mellitus enrolled in Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial (EPISTENT) are shown. A = the rate of death or myocardial infarction (MI) within EPISTENT; B = the 1-year target vessel revascularization (TVR) rates. PTCA = percutaneous transluminal coronary angioplasty.
|
